With Ivan Đikić and Gerhard Hummer two PROXIDRUGS Project Leaders are recognized as Highly Cited Researchers in their fields on...

In a study published in today’s issue of Science, a team around PROXIDRUGS speaker Ivan Đikić reveals how cells deploy ubiquitination and...

The PROXIDRUGS Innovation Management team, together with PROXIDRUGS partners Paul Gehrtz , Principal Scientist MedChem at Merck Gruppe ...

PROXIDRUGS speaker Ivan Đikić has been awarded a prestigious LOEWE-Spitzenprofessur at Goethe University Frankfurt. The Hessian LOEWE...

The PROXIDRUGS consortium was successfully evaluated by an independent jury and will be funded by the Federal Ministry of Education and...

In their latest publication in Chemistry, PROXIDRUGS project leader Felix Hausch and colleagues present the design of ultrapotent FKBP...

PRODXIDRUGS project leader Felix Hausch at TU Darmstadt is coordinating a newly established doctoral network, which is funded by the...

PROXIDRUGS speaker Ivan Đikić ranked #7 in Germany and #141 in the world on Research.com’s 2024 list of ‚Best Molecular Biology...

Today, the German Research Foundation (DFG) announced that the transregional CRC on functionalisation of the ubiquitin system against...

PROXIDRUGS member Xinlai Cheng and his team published their work on how thalidomide derivatives degrade BCL-2, providing important clues...